Pretreatment with SSTF prevents cerebral ischemia-reperfusion injury, says study

Focal cerebral ischemia-reperfusion may lead to neuronal loss in the hippocampus, which is regarded as one of the basic pathological mechanisms underlying cognitive impairment. The neuronal apoptosis plays an important role in cerebral infarction, determining the number of loss of neurons and infarct volume. Growing evidence has suggested that Chinese herbs can inhibit hippocampal apoptosis caused by ischemia-reperfusion. Prof. Shumin Zhao and team from Chengde Medical College in China pretreated rats with scutellaria baicalensis stem-leaf total flavonoid (SSTF) intragastrically for 7 days before focal cerebral ischemia-reperfusion injury models were established using the suture method.

The researchers found that scutellaria baicalensis stem-leaf total flavonoids reduced the infarct volume and apoptosis in hippocampal neurons, restored neurological deficits, and improved the integrity of the blood-brain barrier in rats with cerebral ischemia-reperfusion injury. Meanwhile, SSTF increased the expression of the anti-apoptotic protein Bcl-2 and decreased the expression of the pro-apoptotic protein Bax, but could not prevent apoptosis. These findings, published in the Neural Regeneration Research (Vol. 8, No. 34, 2013), exhibit that SSTF may act on multiple areas and pathways to protect rat hippocampal tissue from ischemia-reperfusion injury, and thus may be useful for the clinical prevention and treatment of ischemic brain injury.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Brain aging may hold the key to predicting Alzheimer’s risk